BY
Benjamin R Yerxa
President

Benjamin R Yerxa insider trades: Opus Genetics (IRD) stock buys and sales

President, Opus Genetics Last trade Oct 23, 2026 41 Form 4 filings
$117K
Sold, last 12 months
1 sale
$0
Bought, last 12 months
0 buys
15
Open-market trades
since 2009
3
Companies
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Benjamin reports to the SEC

Open-market buys and sales

15 trades reported on SEC Form 4, newest first

DateStockTypeValue
Oct 23, 2026IRD↓ Sell$117K
Nov 21, 2024IRD↑ Buy$10K
May 15, 2024CLSD↑ Buy$10K
May 3, 2010ISPH↓ Sell$13K
Apr 1, 2010ISPH↓ Sell$13K
Mar 1, 2010ISPH↓ Sell$12K
Feb 1, 2010ISPH↓ Sell$11K
Jan 4, 2010ISPH↓ Sell$11K
Dec 1, 2009ISPH↓ Sell$11K
Nov 2, 2009ISPH↓ Sell$9K
Oct 1, 2009ISPH↓ Sell$10K
Sep 1, 2009ISPH↓ Sell$11K
Aug 3, 2009ISPH↓ Sell$10K
Jul 1, 2009ISPH↓ Sell$11K
Jun 15, 2009ISPH↓ Sell$31K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other IRD insiders

Open-market trades in the last 12 months

About Benjamin R Yerxa's insider trades

Benjamin R Yerxa is President at Opus Genetics (IRD). Since Jun 15, 2009, Benjamin has reported 2 open-market purchases worth $20K and 13 sales worth $271K on SEC Form 4. In the last 12 months: 1 sale ($117K).

Their filings also include grants and awards (24 filings), option exercises (2 filings), shares withheld for taxes (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every IRD insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.